Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Arvinas And Pfizer To Highlight New Vepdegestrant Data For ESR1-Mutated Advanced Breast Cancer At ESMO 2025

Author: Benzinga Newsdesk | October 13, 2025 07:08am

Presentation to include new patient-reported outcomes (PRO) data from the Phase 3 VERITAC-2 clinical trial

Posted In: ARVN PFE